ZEBOVAC (Ebola Vaccine Trial, Ad26.ZEBOV/MVA-BN-Filo)

Clinical trial NCT04028349 · COMPLETED

Trial details

NCT number: NCT04028349
Sponsor: MRC/UVRI and LSHTM Uganda Research Unit
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ebola Virus Disease

Start date: 2019-08-01
Primary completion: 2021-03-19
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.